To ban or not to ban, the case for reformulating ultra-processed foods

FHS
April 2, 2024
3:34 am

Despite concerns about ultra-processed foods (UPFs) and non-communicable diseases (NCDs), evidence of causality remains unclear; reformulating UPFs may offer significant health advantages.

Lack of awareness contributes to under-reporting of adverse drug reactions

Around 75% of Australians have experienced a bad reaction to a medication, but fewer than half have reported it to a doctor or the Therapeutic

September 24, 2024

Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited – Biotech Investments

, 12/11/2023 / 04:00, EST/EDT – EQS Newswire – Tryp Therapeutics Inc. (Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Canadian Stock Exchange,

December 12, 2023

Coffee-Dementia Link Continues to Unfurl

PHILADELPHIA — Coffee and tea intake were associated with long-term cognitive changes in older adults, two prospective studies presented at the Alzheimer’s Association International Conference

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.